Sanofi: departure of global head of R&D
The group adds that it has begun the internal and external search process for John Reed's succession, stating that Dr. Dietmar Berger has agreed to act as interim head of the R&D organization.
Dr. Berger has been global head of development and chief medical officer since joining Sanofi in 2019, following a career at various pharmaceutical companies, including Genentech, Bayer and Amgen.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction